Vincent Capponi's most recent trade in Cytosorbents Corp was a trade of 12,000 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Feb. 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 24 Feb 2025 | 12,000 | 677,168 (1%) | 0% | 1.1 | 13,560 | Common Stock | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 24 Feb 2025 | 12,000 | 0 | - | - | Series A Right Warrants (right to buy) | ||
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series B Right Warrants | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 665,168 (1%) | 0% | 1 | 31,760 | Common Stock | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | 17 Jan 2025 | 31,760 | 0 | - | - | Subscription Rights (right to buy) | ||
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2025 | 31,760 | 31,760 | - | - | Series A Right Warrants | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 101,000 | 101,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 81,000 | 665,134 (1%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2024 | 48,923 | 48,923 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Vincent Capponi | President & COO | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 13 Dec 2023 | 18,797 | 584,134 (1%) | 0% | 1.3 | 25,000 | Common Stock |
| Cytosorbents Corp | Capponi Vincent | President & COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Dec 2023 | 6,578 | 6,578 | - | - | Common Stock Warrant (Right to Buy) | |
| Cytosorbents Corp | Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 91,000 | 91,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 73,000 | 576,153 (1%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Vincent Capponi | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 42,000 | 42,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.88 per share. | 04 Apr 2023 | 10,000 | 511,989 (1%) | 0% | 2.9 | 28,750 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 86,000 | 86,000 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 69,000 | 512,545 (1%) | 0% | 0 | Common Stock | |
| Cytosorbents Corp | Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 21 Jun 2022 | 2,000 | 443,545 (1%) | 0% | 1.8 | 3,600 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | See Remarks | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 16 Jun 2022 | 3,000 | 441,545 (1%) | 0% | 2 | 6,000 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 23 May 2022 | 3,127 | 438,545 (1%) | 0% | 2.0 | 6,348 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 23 May 2022 | 1,574 | 435,119 (1%) | 0% | 2.0 | 3,211 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | President and COO | Purchase of securities on an exchange or from another person at price $ 2.02 per share. | 23 May 2022 | 299 | 435,418 (1%) | 0% | 2.0 | 605 | Common Stock |
| Cytosorbents Corp | Vincent Capponi | President, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 78,200 | 78,200 | - | - | Stock Option (right to buy) | |
| Cytosorbents Corp | Vincent Capponi | President, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 8.99 per share. | 12 Apr 2021 | 62,215 | 467,756 (1%) | 0% | 9.0 | 559,313 | Common Stock |